These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 4845502)
1. Relief of premenstrual symptoms, dysmenorrhea, and contraceptive tablet intolerance. A preliminary report. Miller JB J Med Assoc State Ala; 1974 Aug; 44(2):57-60. PubMed ID: 4845502 [No Abstract] [Full Text] [Related]
2. Treatment of common gynecologic-endocrinologic symptoms by allergy management procedures. Mabray CR; Burditt ML; Martin TL; Jaynes CR; Hayes JR Obstet Gynecol; 1982 May; 59(5):560-4. PubMed ID: 7200220 [TBL] [Abstract][Full Text] [Related]
3. Use of an oral contraceptive containing drospirenone in an extended regimen. Sillem M; Schneidereit R; Heithecker R; Mueck AO Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):162-9. PubMed ID: 14667328 [TBL] [Abstract][Full Text] [Related]
4. [Use of Progestasert in the treatment of function dysmenorrhea]. Casella S Minerva Ginecol; 1977; 29(7-8):607-10. PubMed ID: 927738 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of vasomotor and congestive vascular disorders in gynecologic practice]. Morin P; Chabrier J Rev Prat; 1972 Nov; 22(30):Suppl:61-8. PubMed ID: 4676238 [No Abstract] [Full Text] [Related]
6. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology]. Müller R; Kempf HJ; Eckert L Zentralbl Gynakol; 1968 Nov; 90(46):1545-55. PubMed ID: 4179333 [No Abstract] [Full Text] [Related]
7. [The progesterone releasing I.U.D. Its indications in function of the menstrual disorders (author's transl)]. Bourgoin P J Gynecol Obstet Biol Reprod (Paris); 1978 Dec; 7(8):1447-51. PubMed ID: 748449 [TBL] [Abstract][Full Text] [Related]
8. [Modern therapy with micronized of progesterone--utrogestan for menstrual disturbances]. Sirakov M Akush Ginekol (Sofiia); 2001; 40 Suppl 5():22-4. PubMed ID: 11785350 [No Abstract] [Full Text] [Related]
9. Use of oral and intrauterine contraceptives. An international panel reports. Greenhill JP Int Surg; 1968 Apr; 49(4):312-8. PubMed ID: 4230720 [No Abstract] [Full Text] [Related]
11. A new progestogen-estrogen combination for gynecologic therapy and contraception. Linthorst G Int J Fertil; 1966; 11(1):35-45. PubMed ID: 5936282 [No Abstract] [Full Text] [Related]
12. [Description of a new method of ovarian inhibition: the "sequential method". Results of its use in the treatment of dysmenorrheas and inter-menstrual disorders. (Study of 172 subjects treated during 573 cycles)]. Gueguen J Rev Fr Gynecol Obstet; 1967 Jun; 62(6):279-86. PubMed ID: 4193181 [No Abstract] [Full Text] [Related]
13. Use of norethindrone .35 mg in disorders of the menstrual cycle. Ferrari AN; Berge I; Rosito CL; Russowsky M; Barbisan AB; Roeche T J Bras Ginecol; 1970 May; 69(5):299-306. PubMed ID: 12259292 [TBL] [Abstract][Full Text] [Related]
14. [Cytologic and colposcopic findings before and after administration of ovulation inhibitors]. Loskant G; Heinen G Zentralbl Gynakol; 1968 May; 90(18):609-13. PubMed ID: 5722983 [No Abstract] [Full Text] [Related]
15. [A new association of megestrol acetate and ethinyl estradiol in gynecologic therapy. Preliminary results]. Signorelli I; Emanueli A Minerva Ginecol; 1969 Apr; 21(8):512-22. PubMed ID: 5815438 [No Abstract] [Full Text] [Related]
16. [Ovulen, its effect on the endometrium, uterine cervix and ovary]. Muller G; Dehalleux JM; Ritter J; Philippe E; Gandar R Gynecol Obstet (Paris); 1968; 67(5):521-32. PubMed ID: 5730661 [No Abstract] [Full Text] [Related]
18. [Drug therapy of menstruation related complaints]. Juvkam KH; Gudim HB Tidsskr Nor Laegeforen; 2011 May; 131(9-10):956-8. PubMed ID: 21606994 [No Abstract] [Full Text] [Related]
19. [Clinical studies in United Arabic Republic with SH 850 (Eugynon), a low dose oral contraceptive, with special reference to its effect on lactation]. Shaaban AH; el-Minawi MF Med Welt; 1970 Oct; 40():1730-4. PubMed ID: 5478123 [TBL] [Abstract][Full Text] [Related]